Trump Says 'No Cash' to mRNA, Investors Say 'Bye Bye'
The Trump administration decided to pull the plug on nearly $500 million meant for mRNA vaccine research, leaving biotech investors nervously clutching their wallets. According to reports, the cut "has made investors more hesitant to back biotechs in this space," which is just a polite way of saying they got cold feet. It's like sitting at a promising restaurant table, then watching the host cancel your reservation right before the appetizer. Science funding or lottery? Either way, no surprise funds went "poof."
Share the Story
Cutting $500M for vaccine research is like closing a lemonade stand right before summer. Genius moves from the admin that make everyone in biotech wanna sell popcorn instead.
Investors gotta be wondering if funding mRNA research feels like betting on a unicorn or a facade. Spoiler: unicorns need money too.
Trump halts mRNA cash flow, biotech investors duck faster than you running from your 8 AM Zoom. Science just got ghosted.
Source: Statnews | Published: 8/14/2025 | Author: Jonathan Wosen and Allison DeAngelis
More Articles in Politics
Pentagon Brings Tech Bros to War Room, Still Confused About AI's Consciousness
Trump Promises Retirement Plan That Matches Generosity of Federal Workersâ Excuses
Trumpâs 108-Minute SOTU Awards Hockey MVP and Racist Sign Waver
Politico Announces Australia Launch for 2026, Because Why Not Start Late?
House Republicans and Democrats Cozy Up Over Epstein Files Like Awkward Middle School Dance Partners
Trump Threatens to Turn State of the Union into the Worldâs Longest Podcast
Americans Trust AI About as Much as They Trust Crooked Politicians
